Volume 2, Issue 2 (2022)

1. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081-2090. 

2. Almasieh M, Levin LA. Neuroprotection in Glaucoma: Animal Models and Clinical Trials. Annu Rev Vis Sci. 2017;3:91-120. 

3. Esporcatte BL, Tavares IM. Normal-tension glaucoma: an update. Arq Bras Oftalmol. 2016;79(4):270-276. 

4. Vera J, Redondo B, Álvarez-Rodríguez M, Molina R, Jiménez R. The intraocular pressure responses to oral academic examination: The influence of perceived levels of public speaking anxiety. Appl Ergon. 2020;88:103158. 

5. Abe RY, Silva TC, Dantas I, Curado SX, Madeira MS, de Sousa LB, et al. Can Psychologic Stress Elevate Intraocular Pressure in Healthy Individuals?. Ophthalmol Glaucoma. 2020;3(6):426-433. 

6. Dada T, Mittal D, Mohanty K, Faiq MA, Bhat MA, Yadav RK, et al. Mindfulness Meditation Reduces Intraocular Pressure, Lowers Stress Biomarkers and Modulates Gene Expression in Glaucoma: A Randomized Controlled Trial. J Glaucoma. 2018;27(12):1061-1067. 

7. Kwon J, Jo YH, Jeong D, Shon K, Kook MS. Baseline Systolic versus Diastolic Blood Pressure Dip and Subsequent Visual Field Progression in Normal-Tension Glaucoma. Ophthalmology. 2019;126(7):967-979. 

8. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):714-720; discussion 829-830